1. Surrey E, Bower J, Hill D, Ramsey J, Surrey M. Clinical and endocrine effects of a
microdose GnRH agonist flare regimen administered to poor responders who are
undergoing in vitro fertilization. Fertil Steril 1998; 69: 419-24.
2. Raga F, Bonill – Musoles F, Casan Em, et al. Recombinant follicle stimulating hormone
stimulation in poor responders with normal basal concentrations of follicle stimulating
hormone and estradiol: improved reproductive outcome. Hum Reprod 1999; 14: 1431 – 4.
3. Lashen H, Ledger W, Lopez – Bernal A, et al. Poor responders to ovulation induction: is
proceeding to in – vitro fertilization worthwhile? Hum Reprod 1999; 14: 964 – 9.
4. Faber B – Mayer J, Cox B, Jones D, et al. Cessation of gonadotropin – releasing hormone
agonist therapy combined with high – dose gonadotropin stimulation yields favorable
pregnancy results in low responders. Fertil Steril 1998; 69: 826- 30.
5. Karande V, Morris R, Rinehart J, et al. Limited success using the “flare" protocol in poor
responders in cycles with low basal follicle – stimulating hormone levels during in vitro
fertilization. Fertil Steril 1997; 67: 900 – 3.
6. Lindheim S, Barad D, Witt B, et al. Short- term gonadotropin suppression with oral
contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J
Assist Reprod Genet 1996; 16: 745–7.
7. Schoolcraft W, Schlenker T, Gee M , Stevens J, Wagley L. Improved controlled ovarian
hyperstimulation in poor responder in vitro fertili zation. Patients with a microdose follicle –
stimulating hormone flare, growth hormone protocol. Fertil Steril 1997; 67: 93 – 7.
8. Mizyen E, sabatini L, Lower A, et al. Does pretreatment with progestogen or oral
contraceptive pills in low responders followed by the GnRH a Flare protocol improve the
outcome of OCP – ET? J Assisted Reproduct Gene 2000; 17 (3): 140 – 46.
9. Russell JB. Precycle estrogen treatment and poor responders. Assisted Reprod Rev 1995;
5: 82 – 89.
10. Keay SD, Liversedge N H, Mathur R S, et al. Assisted conception following poor ovarian
response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997; 104: 521-7.
11. Taylor S N, Lu P , Rye P H, et al .Oral contraceptive , not GnRH suppression , may be
responsible for low endogenous LH during OCP cycle. Fetil Steril 2001; suppl 1 ,76(3):
52 370.
12. Bilgan mm, mahutte NG, Dean N,et al. Effects of pretreatment with an oral Contraceptive
on the time required to achieve pituitary suppression with gonadotrophin – releasing
hormone analogues and on subsequent implantation and pregnancy rates. Fetil Steril 1998
Dec; 70 (6): 106 3-9.
13. Copperma AB, Mukherjee T,Sadler B ,et al. Pre–treatment with oral contraceptive pill
improves outcome in OCP cycles of poor- responders using the GnRH antagonist. Fetil
Steril 2003 suppl.3; 80: S 108.
14. Keltz MD, Sharma P, Stein D E. Comparison of FSH flare in poor responders undergoing
in vitro fertlization (OCP) with and without prior oral contraceptive suppression. Fetil
Steril 2003 suppl. 3 ; 80: S 107.
15. Scott RT, Novort D, Enhancement of ovarian responsiveness with microdoses of
gonadotropin – releasing hormone agonist during ovulation for in vitro fertilization. Fetil
Steril 1994; 61:880- 885.
16. Kolibianakis E M, Albano C, Tournaye H, et al. Pre- treatment with oral contracetive pill
affects adversely implantation rate in OCP /ICSI cycles stimulated with rec – FSH and
GnRH antagonists. Ferti Steri 2003; suppl. 3; 80 : 0-177.
17. World Health Organization. Laboratory manual for the examination of human semen and
sperm–cervical mucus interaction. Cambridge, Eugland: Cambridge university press;
1992.
18. Ran SL, king sland C, campbell S, et al. The long protocol of administration of GnRH is
a superior to the short protocol of ovarian stimu- lation for in vitro fertilization. Fertil
steril 1992; 57: 810 – 4.
19. Flattarelli J, Denis F , Lauria C. Basal antral follicle number and main ovarian diameter
predict cycle camcelled and ovarian responsiveness in ART cycle. Fertil Steril 2000; 74
(3): 512 – 1.
20. Land IA, Yarmalinskaya MI, Dumoulin IC, et al.High dose human menopausal
gonadotropin stimulation in poor responders dose not improve in vitro fertilization
outcome. Fertil Steril 1996; 65: 961-50.
21. Mirkin s, stadtmauer LA,Gibbon WE ,et al. Clinical and endocrine impact of pretreatment
with oral Contraceptive pills in poor responders undergoing OCP with a combination of
microdose flare leuprolide acetate and high dose qonadotropins. Fertil Steril 2003 suppl.
3; 80: p – 205
22. Bancsi L, Broekmans F, Eijkemans M, et al .Predictors of poor ovarian response in
invitro fertilization: a prospective study comparing basal markers of ovarian reserve. Ferti
Steril 2002; 77(2): 328- 336
23. Iwas A, Ando H, kunok, et al. Use of Follicle- Stimulating Hormone test to predict poor
response in In Vitro Fertilization. Obstet 8 Gynecol 2005; 105(3): 645-52.
24. Ramsewak SS, Duffy S, Taylor T, et al. The oral Contraceptive pill effectively permits
cycle batching for an intermittent in vitro fertilization programme in Trinidad and
Tobago. West Indian Med T 2005 Mar; 54 (9): 127- 9.
25. Kovacs p, Bar PE, witt BR. Hypothalamic – pituitary suppression with oral contraceptive
pills does not improve outcome in poor responder patients undergoing in vitro
fertilization – embryo transfer cycle. T Assist Reprod Genet 2001 Jul ; 18 (7) : 391 – 4.
26. Talebian S, Krey L C , Noyes N. Use of oral contraceptives with GnRH antgonists and
recombinant gonadotropin sin OCP cycles have no deleterious effect on pregnancy
outcome. Fetil Steril 2004 suppl . 2; 82: S 234.
27. Branig, E f, Estess M. A. minimal stimulation OCP using clomiphen citrate and oral
contraceptive pill pretreatment for LH suppression. Fetil Steril 2000; 7(3): 587- 590
28. Popovic- Todorvic B, Loft A, Lindhard A, et al. A prospective study of predictive factors
of ovarian response in “standard” OCP/ ICSI patients treated with recombinant FSH, A
suggestion for a recombinant FSH dosage normogram. Hum Reprod 2003; 18 (4): 781-
787.
29. Templeton A, Morris ID, parslow W. Factors that affect outcome of in- vitro fertilization
trea ment. Lancet 1996; 348: 1402-6.
30. Kupka M,Dorn C, Richter O, et al. Impact of reproductive history on in vitro fertilization
and intracytoplasmic sperm injection outcome: evidence from the German OCP Registry.
Ferti Steril 2003; 60(3): 508- 16.
31. Ashkenazi J, orvieto R, Gold – Deuteh R, et al. The impact of woman’s age and sperm
parameters on fertilization rates in OCP cycles. Europ J obstetrics 8 Gynecol Reproduct
Biol 1996; 60 (2): 155- 9.
)